Microchimica Acta

, 186:610 | Cite as

Molecularly imprinted gelatin nanoparticles for DNA delivery and in-situ fluorescence imaging of telomerase activity

  • Yida Zhang
  • Yuan Zhang
  • Chen Ma
  • Yaya Wang
  • Shuai Mu
  • Xiaoyan Liu
  • Xiaoyu ZhangEmail author
  • Haixia ZhangEmail author
Original Paper


DNA-loaded molecularly imprinted gelatin nanoparticles (GDMI-NPs) were prepared to deliver the Cy3- and Cy5-labelled DNA probe to a tumor region. This allows the activity of telomerase can be detected over 3–400 cells with a low detection limit (3 cells). Fluorescence images were acquired at an excitation wavelength of 535 nm and the emission from the green channel (550–580 nm; label Cy3) and the red channel (650–680 nm; label Cy5). HeLa cells and HepG2 cells were both used to test the performance of GDMI-NPs. Experimental results confirmed the GDMI-NPs has hardly retained in liver and spleen tissue, and its circulated time was longer than that of non-imprinted nanoparticles in blood. The ability of GDMI-NPs to resist immuno stress and anti-macrophage phagocytosis shows great potential for cancer diagnosis and as a drug carrier.

Graphical abstract

Highly DNA-loaded molecularly imprinted gelatin nanoparticles (GDMI-NPs) were prepared to deliver the Cy3-labelled DNA probe to a cancer region, and realization of telomerase in situ fluorescence imaging at the tumor site.


Transferrin Molecular imprinting Gene delivery Protein coronas Immunological stress 



This research was financially supported by the National Natural Science Foundation of China (No. 21575055) and the Research Funds for the Central Universities (lzujbky-2017-k09).

Compliance with ethical standards

The study using mice as sample has been approved by the Lanzhou University Ethics Committee, and has been performed in accordance with the ethical standards.

Informed consent was obtained from all individual participants included in the study.

The author(s) declare that they have no competing interests.

Supplementary material

604_2019_3671_MOESM1_ESM.doc (3.4 mb)
ESM 1 (DOC 3466 kb)


  1. 1.
    Wang HF, Ma RN, Sun F, Jia LP, Zhang W, Shang L, Xue QW, Jia WL, Wang HS (2018) A versatile label-free electrochemical biosensor for circulating tumor DNA based on dual enzyme assisted multiple amplification strategy. Biosens Bioelectron 122:224–230. CrossRefPubMedGoogle Scholar
  2. 2.
    Miao XM, Cheng ZY, Ma HY, Li ZB, Xue N, Wang P (2017) A novel and label-free platform for MicroRNA detection based on the fluorescence quenching of positively charged gold nanoparticles to ag nanoclusters. Anal Chem 90:1098–1103. CrossRefPubMedGoogle Scholar
  3. 3.
    Hong M, Xu LD, Xue QW, Li L, Tang B (2016) Fluorescence imaging of intracellular telomerase activity using enzyme-free signal amplification. Anal Chem 88:12177–12182. CrossRefPubMedGoogle Scholar
  4. 4.
    Franch O, Han X, Marcussen LB, Givskov A, Andersen MB, Godbole AA, Harmsen C, Nørskov-Lauritsen N, Thomsen J, Pedersen FS, Wang Y, Shi D, Wejse C, Pødenphant L, Nagaraja V, Bertl J, Stougaard M, Ho YP, Hede MS, Labouriau R, Knudsen BR (2019) A new DNA sensor system for specific and quantitative detection of mycobacteria. Nanoscale 11:587–597. CrossRefPubMedGoogle Scholar
  5. 5.
    Sahin U, Kariko K, Tureci O (2014) mRNA-based therapeutics - developing a new class of drugs. Nat Rev Drug Discov 13:759–780. CrossRefPubMedGoogle Scholar
  6. 6.
    Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG (2014) Non-viral vectors for gene-based therapy. Nat Rev Genet 15:541–555. CrossRefPubMedGoogle Scholar
  7. 7.
    Takeuchi T, Kitayama Y, Sasao R, Yamada T, Toh K, Matsumoto Y, Kataoka K (2017) Molecularly imprinted Nanogels acquire stealth in situ by cloaking themselves with native Dysopsonic proteins. Angew Chem Int Ed 56:7088–7092. CrossRefGoogle Scholar
  8. 8.
    Fenton OS, Kauffman KJ, McClellan RL, Kaczmarek JC, Zeng MD, Andresen JL, Rhym LH, Heartlein MW, DeRosa F, Anderson DG (2018) Customizable lipid nanoparticle materials for the delivery of siRNAs and mRNAs. Angew Chem Int Ed 57:13582–13586. CrossRefGoogle Scholar
  9. 9.
    Young S, Wong M, Tabata Y, Mikos AG (2005) Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 109:256–274. CrossRefPubMedGoogle Scholar
  10. 10.
    Ida T, Manorama S (2011) Preparation and characterization of methyleneblue-SDS- multiwalled carbon nanotubes nanocompositefor the detection of hydrogen peroxide. Microchim Acta 174:233–230. CrossRefGoogle Scholar
  11. 11.
    Choi D, Heo J, Hong J (2018) Controllable drug release from nano-layered hollow carrier by nonomnipresent enzyme in human condition. Nanoscale 10:18228–18237. CrossRefPubMedGoogle Scholar
  12. 12.
    Cho EC, Kim JW (2008) A. Fernandez-Nieves, D.a. Weitz, highly responsive hydrogel scaffolds formed by three-dimensional organization of microgel nanoparticles. Nano Lett 8:168–172. CrossRefPubMedGoogle Scholar
  13. 13.
    Elzoghby AO (2013) Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research. J Control Release 172:1075–1091. CrossRefPubMedGoogle Scholar
  14. 14.
    Liu YC, Zhang CH, Li XZ, Wu DC (2017) A self-monitored fluorescence DNA anticounterfeiting system based on silica coated SYBR green I/DNA gelatin nanoparticles. J Mater Chem C 5:5939–5948. CrossRefGoogle Scholar
  15. 15.
    Schirhagl R (2014) Bioapplications for molecularly imprinted polymers. Anal Chem 86:250–261. CrossRefPubMedGoogle Scholar
  16. 16.
    Guan XJ, Zhu XY, Yu BF, Zhao T, Zhang HX (2015) Preparation of temperature sensitive molecularly imprinted polymer coatings on nickel foam for determination of ofloxacin in Yellow River water by solid-phase microextraction. RSC Adv 5:91716–91722. CrossRefGoogle Scholar
  17. 17.
    Yang C, Ji XF, Cao WQ, Wang J, Zhang Q, Zhong TL, Wang Y (2019) Molecularly imprinted polymer based sensor directly responsive to attomole bovine serum albumin. Talanta 1:402–407. CrossRefGoogle Scholar
  18. 18.
    Deng JZ, Chen S, Chen JL, Ding HL, Deng DW, Xie ZY (2018) Self-reporting colorimetric analysis of drug release by molecular imprinted structural color contact lens. ACS Appl Mater Interfaces 10:34611–34617. CrossRefPubMedGoogle Scholar
  19. 19.
    Bernard A, Delamarche E, Schmid H, Michel B, Bosshard HR, Biebuyck H (1998) Printing patterns of proteins. Langmuir 14:2225–2229. CrossRefGoogle Scholar
  20. 20.
    Li SW, Yang KG, Deng N, Min Y, Liu LK, Zhang LH, Zhang YK (2016) Thermoresponsive epitope surface-imprinted Nanoparticlesfor specific capture and release of target protein from human plasma[J]. ACS Appl Mater Interfaces 8:5747–5751. CrossRefPubMedGoogle Scholar
  21. 21.
    Mao X, Liang WA, Peng XH, Tang SQ (2010) Recent Progress in protein imprinting technology. Recent Pat Nanotechnol 4:85–99. CrossRefPubMedGoogle Scholar
  22. 22.
    Zhang Y, Deng CY, Liu S, Wu J, Chen ZB, Li C, Lu WY (2015) Active targeting of tumors through conformational epitope imprinting. Angew Chem Int Ed 54:5157–5160. CrossRefGoogle Scholar
  23. 23.
    Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in Cancer chemotherapy: mechanism of Tumoritropic accumulation of proteins and the antitumor agent Smancs. Cancer Res 46:6387–6392. CrossRefPubMedGoogle Scholar
  24. 24.
    Zhang YD, Huang QW, Ma C, Liu XY, Zhang HX (2018) Magnetic fluorescent molecularly imprinted nanoparticles for detection and separation of transferrin in human serum. Talanta 188:540–545. CrossRefPubMedGoogle Scholar
  25. 25.
    Hoshia K, Matsumotob Y, Itoa H, Saitob K, Hondac T, Yamaguchid Y, Hashimotoa Y (2017) A unique glycan-isoform of transferrin in cerebrospinal fluid: a potential diagnostic marker for neurological diseases. BBA-Biomembr 1861:2473–2478. CrossRefGoogle Scholar
  26. 26.
    Afzal SM, Shareef MZ, Kishan V (2016) Transferrin tagged lipid nanoemulsion of docetaxel for enhanced tumor targeting. J Drug Deliv Sci Technol 36:175–172. CrossRefGoogle Scholar
  27. 27.
    Skikne BS, Flowers CH, Cook JD (1990) Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 75:1870–1876. CrossRefPubMedGoogle Scholar
  28. 28.
    Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR (1997) Telomerase catalytic subunit homologs from fission yeast and Huma. Science 277:955–958. CrossRefPubMedGoogle Scholar
  29. 29.
    Meng FY, Xu YY, Dong WF, Tang YG, Miao P (2018) A PCR-free voltammetric telomerase activity assay using a substrateprimer on a gold electrode and DNA-triggered captureof gold nanoparticles. Microchim Acta 185:398. CrossRefGoogle Scholar
  30. 30.
    Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GMW, Wright E, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015. CrossRefGoogle Scholar
  31. 31.
    Li Y, Liu BW, Li X, Wei QL (2010) Highly sensitive electrochemical detection of human telomerase activity based on bio-barcode method. Biosens Bioelectron 25:2543–2547. CrossRefPubMedGoogle Scholar
  32. 32.
    Wang GW, Wang H, Cao S, Xiang W, Li T, Yang MH (2019) Electrochemical determination of the activity and inhibitionof telomerase based on the interaction of DNA with molybdate. Microchim Acta 186:96. CrossRefGoogle Scholar
  33. 33.
    Yang XJ, Zhang K, Zhang TT, Xu JJ, Chen HY (2017) A reliable FRET probe based on structure-switching DNA for Ratiometric sensing of telomerase in living cells. Anal Chem 89:4216–4222. CrossRefPubMedGoogle Scholar
  34. 34.
    Coester CJ, Langer K, Briesen HV, Kreuter J (2000) Gelatin nanoparticles by two step desolvation - a new preparation method, surface modifications and cell uptake. J Microencapsul 17:187–193. CrossRefPubMedGoogle Scholar
  35. 35.
    Kang J, Huo FJ, Zhang YB, Chao JB, Glass TE, Yin CX (2019) A novel near-infrared Ratiometric fluorescent probe for cyanide and its bioimaging applications. Spectrochim Acta A Mol Biomol Spectrosc 209:95–99. CrossRefPubMedGoogle Scholar
  36. 36.
    Lackowicz J (2006) Principle of Fluorescence Spectroscopy, 3th edn. Springer, New YorkCrossRefGoogle Scholar
  37. 37.
    Park JH, Gu L, Maltzahn GV, Ruoslahti E, Bhatia SN, Sailor MJ (2009) Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nature 8:331–336. CrossRefGoogle Scholar
  38. 38.
    Yegin Y, Gökhan Y, Ömer K, Yegin C, Müfrettin MS (2016) Molecularly imprinted materials for controlled release systems. Advanced Molecularly Imprinting Materials. John Wiley & Sons, Inc. CrossRefGoogle Scholar
  39. 39.
    Fernando Y, Anuj C, Angel C, Carmen AL (2011) Timolol-imprinted soft contact lenses: influence of the template: functional monomer ratio and the hydrogel thickness. J Appl Polym Sci 122:1333–1340. CrossRefGoogle Scholar
  40. 40.
    Liu L, Zhong T, Xu QQ, Chen Y (2015) Efficient molecular imprinting strategy for quantitative targeted proteomics of human transferrin receptor in depleted human serum. Anal Chem 87:10910–10919. CrossRefPubMedGoogle Scholar
  41. 41.
    Wang Y, Cheng FX, Yuan XL, Tang WJ, Shi JB, Liao CZ, Liu XH (2016) Dihydropyrazole derivatives as telomerase inhibitors: structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo. Eur J Med Chem 112:231–251. CrossRefPubMedGoogle Scholar
  42. 42.
    Chen C, Zhang YM, Wang Y, Huang DJ, Xi YM, Qi YM (2011) Synergic effect of 3′-azido-3′-deoxythymidine and arsenic trioxide in suppressing hepatoma cells. Anti-Cancer Drugs 22:435–443. CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  1. 1.College of Chemistry and Chemical EngineeringLanzhou UniversityLanzhouChina
  2. 2.School of Basic Medical ScienceLanzhou UniversityLanzhouChina

Personalised recommendations